ConvaTec Group Plc ("the Company") - Total Voting Rights

Reading, United Kingdom (31 March 2022)

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 March 2022, the Company's issued capital with voting rights consisted of 2,034,572,935 ordinary shares of 10p each ('Shares'). The Company does not hold any Shares in Treasury at the date of this disclosure.

The above figure (2,034,572,935) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules. 

Enquiries:

Analysts and Investors

Kate Postans, Vice President, Investor Relations                                                +44 (0)7826 447 807

ir@convatec.com

Media

Buchanan: Charles Ryland/Chris Lane                                                                +44 (0)207 466 5000  

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com